308 related articles for article (PubMed ID: 1433987)
21. Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation.
Mosley B; De Imus C; Friend D; Boiani N; Thoma B; Park LS; Cosman D
J Biol Chem; 1996 Dec; 271(51):32635-43. PubMed ID: 8999038
[TBL] [Abstract][Full Text] [Related]
22. Molecular genetics of leukemia inhibitory factor (LIF) and its receptor.
Gough NM
Growth Factors; 1992; 7(3):175-9. PubMed ID: 1457125
[No Abstract] [Full Text] [Related]
23. Reconstitution of the functional mouse oncostatin M (OSM) receptor: molecular cloning of the mouse OSM receptor beta subunit.
Tanaka M; Hara T; Copeland NG; Gilbert DJ; Jenkins NA; Miyajima A
Blood; 1999 Feb; 93(3):804-15. PubMed ID: 9920829
[TBL] [Abstract][Full Text] [Related]
24. Influence of subunit combinations on signaling by receptors for oncostatin M, leukemia inhibitory factor, and interleukin-6.
Kuropatwinski KK; De Imus C; Gearing D; Baumann H; Mosley B
J Biol Chem; 1997 Jun; 272(24):15135-44. PubMed ID: 9182534
[TBL] [Abstract][Full Text] [Related]
25. Cloning and characterization of a specific receptor for mouse oncostatin M.
Lindberg RA; Juan TS; Welcher AA; Sun Y; Cupples R; Guthrie B; Fletcher FA
Mol Cell Biol; 1998 Jun; 18(6):3357-67. PubMed ID: 9584176
[TBL] [Abstract][Full Text] [Related]
26. Structural and functional studies on the leukemia inhibitory factor receptor (LIF-R): gene and soluble form of LIF-R, and cytoplasmic domain of LIF-R required for differentiation and growth arrest of myeloid leukemic cells.
Tomida M
Leuk Lymphoma; 2000 May; 37(5-6):517-25. PubMed ID: 11042511
[TBL] [Abstract][Full Text] [Related]
27. Oncostatin M and leukemia inhibitory factor do not use the same functional receptor in mice.
Ichihara M; Hara T; Kim H; Murate T; Miyajima A
Blood; 1997 Jul; 90(1):165-73. PubMed ID: 9207450
[TBL] [Abstract][Full Text] [Related]
28. Leukemia inhibitory factor (LIF) and oncastsin M (OSM) high affinity binding require additional receptor subunits besides GP130 and GP190.
Heymann D; Godard A; Raher S; Bentouimou N; Blanchard F; Cherel M; Hallet MM; Jacques Y
Cytokine; 1996 Mar; 8(3):197-205. PubMed ID: 8833034
[TBL] [Abstract][Full Text] [Related]
29. Oncostatin M (OSM) inhibits the differentiation of pluripotent embryonic stem cells in vitro.
Rose TM; Weiford DM; Gunderson NL; Bruce AG
Cytokine; 1994 Jan; 6(1):48-54. PubMed ID: 8003633
[TBL] [Abstract][Full Text] [Related]
30. Leukemia inhibitory factor: part of a large ingathering family.
Taupin JL; Pitard V; Dechanet J; Miossec V; Gualde N; Moreau JF
Int Rev Immunol; 1998; 16(3-4):397-426. PubMed ID: 9505197
[TBL] [Abstract][Full Text] [Related]
31. Differential effects of oncostatin M and leukaemia inhibitory factor expression in astrocytoma cells.
Kasza A; Rogowski K; Kilarski W; Sobota R; Bernas T; Dobrucki J; Travis J; Koj A; Bugno M; Kordula T
Biochem J; 2001 Apr; 355(Pt 2):307-14. PubMed ID: 11284716
[TBL] [Abstract][Full Text] [Related]
32. Leukemia inhibitory factor (LIF) and LIF receptor in human lung. Distribution and regulation of LIF release.
Knight DA; Lydell CP; Zhou D; Weir TD; Robert Schellenberg R; Bai TR
Am J Respir Cell Mol Biol; 1999 Apr; 20(4):834-41. PubMed ID: 10101017
[TBL] [Abstract][Full Text] [Related]
33. Maintenance of the pluripotential phenotype of embryonic stem cells through direct activation of gp130 signalling pathways.
Yoshida K; Chambers I; Nichols J; Smith A; Saito M; Yasukawa K; Shoyab M; Taga T; Kishimoto T
Mech Dev; 1994 Feb; 45(2):163-71. PubMed ID: 8199053
[TBL] [Abstract][Full Text] [Related]
34. Proliferative responses and binding properties of hematopoietic cells transfected with low-affinity receptors for leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor.
Gearing DP; Ziegler SF; Comeau MR; Friend D; Thoma B; Cosman D; Park L; Mosley B
Proc Natl Acad Sci U S A; 1994 Feb; 91(3):1119-23. PubMed ID: 8302840
[TBL] [Abstract][Full Text] [Related]
35. Testicular leukemia inhibitory factor (LIF) and LIF receptor mediate phosphorylation of signal transducers and activators of transcription (STAT)-3 and STAT-1 and induce c-fos transcription and activator protein-1 activation in rat Sertoli but not germ cells.
Jenab S; Morris PL
Endocrinology; 1998 Apr; 139(4):1883-90. PubMed ID: 9528974
[TBL] [Abstract][Full Text] [Related]
36. Characteristic localization of gp130 (the signal-transducing receptor component used in common for IL-6/IL-11/CNTF/LIF/OSM) in the rat brain.
Watanabe D; Yoshimura R; Khalil M; Yoshida K; Kishimoto T; Taga T; Kiyama H
Eur J Neurosci; 1996 Aug; 8(8):1630-40. PubMed ID: 8921254
[TBL] [Abstract][Full Text] [Related]
37. Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony-stimulating factor, and interleukin 6.
Rose TM; Bruce AG
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8641-5. PubMed ID: 1717982
[TBL] [Abstract][Full Text] [Related]
38. Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130.
Gearing DP; Thut CJ; VandeBos T; Gimpel SD; Delaney PB; King J; Price V; Cosman D; Beckmann MP
EMBO J; 1991 Oct; 10(10):2839-48. PubMed ID: 1915266
[TBL] [Abstract][Full Text] [Related]
39. Expression of leukemia inhibitory factor (LIF)/interleukin-6 family cytokines and receptors during in vitro osteogenesis: differential regulation by dexamethasone and LIF.
Liu F; Aubin JE; Malaval L
Bone; 2002 Jul; 31(1):212-9. PubMed ID: 12110437
[TBL] [Abstract][Full Text] [Related]
40. Leukemia inhibitory factor, interleukin-6, and their receptors are expressed transiently in the olfactory mucosa after target ablation.
Nan B; Getchell ML; Partin JV; Getchell TV
J Comp Neurol; 2001 Jun; 435(1):60-77. PubMed ID: 11370011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
